Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

67.76 +1.60 (+2.42%)
Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Edwards Lifesciences

< Previous 1 2 3 Next >
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion of Market Capitalization - Hagens Berman
SAN FRANCISCO - (NewMediaWire) - November 14, 2024 - Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. 
Via TheNewswire.com
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion of Market Capitalization - Hagens Berman
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
From The Rosen Law Firm PA
Via GlobeNewswire
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
EW INVESTORS: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Edwards Lifesciences Corporation Class Action
From Robbins LLP
Via GlobeNewswire
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
TOP RANKED ROSEN LAW FIRM Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
From The Rosen Law Firm PA
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Edwards Lifesciences Corporation to Contact Us to Have Their Losses Evaluated Today
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
From Edwards Lifesciences Corporation
Via Business Wire
TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
From Edwards Lifesciences Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TD, Edwards, and UPS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
From Edwards Lifesciences Corporation
Via Business Wire
EW CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) and Lead Plaintiff Deadline on December 13, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
EW CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) and Lead Plaintiff Deadline on December 13, 2024
NEW YORK - (NewMediaWire) - October 28, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or the... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Edwards Lifesciences Corporation Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
EDWARDS LIFESCIENCES DEADLINE FOR LEADERSHIP is December 13, 2024 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
EDWARDS LIFESCIENCES DEADLINE FOR LEADERSHIP is December 13, 2024 in a Securities Fraud Lawsuit - Contact Kaplan Fox &amp; Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - October 25, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or... 
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal
Edwards Lifesciences Reports Third Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman
EW Investors with Losses Encouraged to Contact the Firm 
From Hagens Berman Sobol Shapiro LLP
Via GlobeNewswire
EW DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before December 13, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
EW DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before December 13, 2024
NEW YORK, NY - (NewMediaWire) - October 24, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
EDWARDS LIFESCIENCES DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on December 13, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
EDWARDS LIFESCIENCES DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on December 13, 2024
NEW YORK, NY - (NewMediaWire) - October 23, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.